Genetic testing, which provides conclusive results in up to 80% of patients, particularly directed to the three most prevalent LQTS-susceptible genes (KCNQ1, KCNH2, and SCN5A) is also recommended in all patients with diagnosis of LQTS [10]. Here, KCNH2 is linked to familial long QT syndrome.